These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

625 related items for PubMed ID: 16713661

  • 1. Immune response to influenza vaccination in community-dwelling Chinese elderly persons.
    Hui SL, Chu LW, Peiris JS, Chan KH, Chu D, Tsui W.
    Vaccine; 2006 Jun 19; 24(25):5371-80. PubMed ID: 16713661
    [Abstract] [Full Text] [Related]

  • 2. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA.
    Pediatrics; 2006 Sep 19; 118(3):e570-8. PubMed ID: 16950948
    [Abstract] [Full Text] [Related]

  • 3. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.
    Vaccine; 2009 Aug 27; 27(39):5357-62. PubMed ID: 19607951
    [Abstract] [Full Text] [Related]

  • 4. An influenza A/H3 outbreak during the 2004/2005 winter in elderly vaccinated people living in a nursing home.
    Iorio AM, Neri M, Lepri E, Camilloni B, Basileo M, Sigismondi N, Fabiani C, Calzoletti L, Puzelli S, Donatelli I.
    Vaccine; 2006 Nov 10; 24(44-46):6615-9. PubMed ID: 16828941
    [Abstract] [Full Text] [Related]

  • 5. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?
    Skowronski DM, Tweed SA, De Serres G.
    J Infect Dis; 2008 Feb 15; 197(4):490-502. PubMed ID: 18275271
    [Abstract] [Full Text] [Related]

  • 6. Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients.
    de Roux A, Marx A, Burkhardt O, Schweiger B, Borkowski A, Banzhoff A, Pletz MW, Lode H.
    Vaccine; 2006 Mar 06; 24(10):1537-42. PubMed ID: 16288937
    [Abstract] [Full Text] [Related]

  • 7. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.
    Cools HJ, Gussekloo J, Remmerswaal JE, Remarque EJ, Kroes AC.
    J Med Virol; 2009 May 06; 81(5):908-14. PubMed ID: 19319953
    [Abstract] [Full Text] [Related]

  • 8. Kinetics of the antibody response to seasonal influenza vaccination among the elderly.
    Kositanont U, Assantachai P, Wasi C, Puthavathana P, Praditsuwan R.
    Viral Immunol; 2012 Dec 06; 25(6):471-6. PubMed ID: 23061793
    [Abstract] [Full Text] [Related]

  • 9. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.
    Nabeshima S, Kashiwagi K, Murata M, Kanamoto Y, Furusyo N, Hayashi J.
    J Med Virol; 2007 Mar 06; 79(3):320-5. PubMed ID: 17245715
    [Abstract] [Full Text] [Related]

  • 10. Co-administration of l-cystine and l-theanine enhances efficacy of influenza vaccination in elderly persons: nutritional status-dependent immunogenicity.
    Miyagawa K, Hayashi Y, Kurihara S, Maeda A.
    Geriatr Gerontol Int; 2008 Dec 06; 8(4):243-50. PubMed ID: 19149835
    [Abstract] [Full Text] [Related]

  • 11. Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence.
    Song JY, Cheong HJ, Hwang IS, Choi WS, Jo YM, Park DW, Cho GJ, Hwang TG, Kim WJ.
    Vaccine; 2010 May 21; 28(23):3929-35. PubMed ID: 20394719
    [Abstract] [Full Text] [Related]

  • 12. Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older.
    Kerzner B, Murray AV, Cheng E, Ifle R, Harvey PR, Tomlinson M, Barben JL, Rarrick K, Stek JE, Chung MO, Schödel FP, Wang WW, Xu J, Chan IS, Silber JL, Schlienger K.
    J Am Geriatr Soc; 2007 Oct 21; 55(10):1499-507. PubMed ID: 17908055
    [Abstract] [Full Text] [Related]

  • 13. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H, Jeganathan S, Smith DE, Robertson P, Barnes T, Furner V.
    HIV Med; 2012 Jul 21; 13(6):352-7. PubMed ID: 22296264
    [Abstract] [Full Text] [Related]

  • 14. Comparison between a conventional subunit vaccine and the MF59-adjuvanted subunit influenza vaccine in the elderly: an evaluation of the safety, tolerability and immunogenicity.
    Sindoni D, La Fauci V, Squeri R, Cannavò G, Bacilieri S, Panatto D, Gasparini R, Amicizia D.
    J Prev Med Hyg; 2009 Jun 21; 50(2):121-6. PubMed ID: 20099444
    [Abstract] [Full Text] [Related]

  • 15. Serum antibodies against circulating influenza strains among vaccinated and unvaccinated general practitioners during two consecutive years (2002-2003).
    Michiels B, Philips H, Coenen S, Denekens J, Van Royen P.
    Vaccine; 2006 Apr 12; 24(16):3145-52. PubMed ID: 16490288
    [Abstract] [Full Text] [Related]

  • 16. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community.
    Praditsuwan R, Assantachai P, Wasi C, Puthavatana P, Kositanont U.
    J Med Assoc Thai; 2005 Feb 12; 88(2):256-64. PubMed ID: 15962680
    [Abstract] [Full Text] [Related]

  • 17. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
    Sugimura T, Ito Y, Tananari Y, Ozaki Y, Maeno Y, Yamaoka T, Kudo Y.
    Vaccine; 2008 May 23; 26(22):2700-5. PubMed ID: 18436353
    [Abstract] [Full Text] [Related]

  • 18. The immunogenicity of intradermal influenza vaccination in COPD patients.
    Chuaychoo B, Wongsurakiat P, Nana A, Kositanont U, Maranetra KN.
    Vaccine; 2010 May 28; 28(24):4045-51. PubMed ID: 20412877
    [Abstract] [Full Text] [Related]

  • 19. Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks.
    Buxton JA, Skowronski DM, Ng H, Marion SA, Li Y, King A, Hockin J.
    J Infect Dis; 2001 Jul 15; 184(2):188-91. PubMed ID: 11424016
    [Abstract] [Full Text] [Related]

  • 20. Occurrence and protective level of influenza infections using serology in patients with COPD in vaccination study.
    Kositanont U, Kanyok R, Wasi C, Wongsurakiat P, Suthamsmai T, Maranetra N.
    J Med Assoc Thai; 2004 Aug 15; 87(8):964-9. PubMed ID: 15471303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.